0001209191-17-043425.txt : 20170705 0001209191-17-043425.hdr.sgml : 20170705 20170705174754 ACCESSION NUMBER: 0001209191-17-043425 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170703 FILED AS OF DATE: 20170705 DATE AS OF CHANGE: 20170705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dimension Therapeutics, Inc. CENTRAL INDEX KEY: 0001592288 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463942159 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 840 MEMORIAL DRIVE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-401-0011 MAIL ADDRESS: STREET 1: 840 MEMORIAL DRIVE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jenkins Annalisa CENTRAL INDEX KEY: 0001639481 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37601 FILM NUMBER: 17948739 MAIL ADDRESS: STREET 1: C/O ARDELYX, INC. STREET 2: 34715 ARDENWOOD BLVD, SUITE 100 CITY: FREMONT STATE: CA ZIP: 94555 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-03 0 0001592288 Dimension Therapeutics, Inc. DMTX 0001639481 Jenkins Annalisa C/O DIMENSION THERAPEUTICS, INC. 840 MEMORIAL DRIVE, 4TH FLOOR CAMBRIDGE MA 02139 1 1 0 0 President and CEO Stock Option (Right to Buy) 1.35 2017-07-03 4 A 0 150000 0.00 A 2027-07-02 Common Stock 150000 150000 D This option shall vest on December 31, 2018, subject to the Reporting Person's continued service to the Issuer on such date. /s/ Jean Franchi, as Attorney-in-Fact for Annalisa Jenkins 2017-07-05